Home > Insider Trading > Filing (0001209191-20-042215)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636050	Axovant Gene Therapies Ltd.	AXGT	Pharmaceutical Preparations (2834)	981333697

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1731741	Pavan Cheruvu	C/O Axovant Gene Therapies Ltd. 11 Times Square, 33Rd Floor New York NY 10036	Principal Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-07-08	37,500	$2.74	57,836	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the sales of shares by the reporting person at $3.09 per share on June 11, 2020. The reporting person has paid to the Issuer the $3,616.37 loss avoided by the reporting person in connection with the short-swing transaction.
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.70 to $2.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote.